about
Total Laparoscopic Hysterectomy With Percutaneous (Percuvance) Instruments: New Frontier of Minimally Invasive Gynecological Surgery.Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trial-NCT02324595): a feasibility study.Laparoscopic, minilaparoscopic, single-port and percutaneous hysterectomy: Comparison of perioperative outcomes of minimally invasive approaches in gynecologic surgery.The Senhance™ surgical robotic system ("Senhance") for total hysterectomy in obese patients: a pilot study.Needleoscopic Conservative Staging of Borderline Ovarian Tumor.Laparoscopic Management of Abdominal Pregnancy.Minimally invasive versus standard laparotomic interval debulking surgery in ovarian neoplasm: A single-institution retrospective case-control study.Total laparoscopic hysterectomy using a percutaneous surgical system: a pilot study towards scarless surgery.Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome.Use of robot-specific resources and operating room times: the case of Telelap Alf-X robotic hysterectomy.Telelap ALF-X vs Standard Laparoscopy for the Treatment of Early-Stage Endometrial Cancer: A Single-Institution Retrospective Cohort Study.Out-of-the-box pelvic surgery including iliopsoas resection for recurrent gynecological malignancies: Does that make sense? A single-institution case-series.Telelap Alf-X-Assisted Laparoscopy for Ovarian Cyst Enucleation: Report of the First 10 Cases.TELELAP ALF-X Robotic-assisted Laparoscopic Hysterectomy: Feasibility and Perioperative Outcomes.Minilaparoscopic versus single-port total hysterectomy: a randomized trial.Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience.Single-Institution Propensity-Matched Study to Evaluate the Psychological Effect of Minimally Invasive Interval Debulking Surgery vs Standard Laparotomic Treatment: From Body to Mind and Back.Resectability and Vascular Management of Retroperitoneal Gynecological Malignancies: A Large Single-institution Case-Series.3 mm Senhance robotic hysterectomy: a step towards future perspectives.Total Laparoscopic (S-LPS) versus TELELAP ALF-X Robotic-Assisted Hysterectomy: A Case-Control Study.Robotic versus laparoscopic radical hysterectomy in early cervical cancer: A case matched control study.Laparoscopic vs. Transvaginal Cuff Closure After Total Laparoscopic Hysterectomy: A Randomized Trial by the Italian Society of Gynecologic Endoscopy.Laparoscopic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study.Learning a new robotic surgical device: Telelap Alf X in gynaecological surgery.Randomized study comparing use of THUNDERBEAT technology vs standard electrosurgery during laparoscopic radical hysterectomy and pelvic lymphadenectomy for gynecologic cancer.One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer.Clinical Impact of a Surgical Energy Device in Advanced Ovarian Cancer Surgery Including Bowel Resection.Ultrasound appearance of retroperitoneal pelvic Solitary Fibrous TumorUpfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancerLaparoscopic, minilaparoscopic and single-port hysterectomy: perioperative outcomesTotal laparoendoscopic single-site surgery (LESS) hysterectomy in low-risk early endometrial cancer: a pilot studyThe new robotic TELELAP ALF-X in gynecological surgery: single-center experienceLaparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experienceTelelap ALF-X total hysterectomy for early stage endometrial cancer: New frontier of robotic gynecological surgeryMesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: prognostic role and clinical considerationsThree-Dimensional Versus Two-Dimensional Radical Laparoscopic Hysterectomy for Endometrial and Cervical Cancer: A Prospective Randomized TrialReplyTotal laparoscopic hysterectomy for enlarged uteri: factors associated with the rate of conversion to open surgeryThe INTERNATIONAL MISSION study: minimally invasive surgery in ovarian neoplasms after neoadjuvant chemotherapyMinimally invasive salvage lymphadenectomy in gynecological cancer patients: A single institution series
P50
Q38589549-2BA56402-5BBF-4005-8212-2DA0ED37E6B6Q38623416-D3BDC5A8-B249-4787-88EA-B36EFD2D3D02Q38655333-613F681B-3A0A-46BC-8642-2A9CD3183DC0Q38720767-A97E101F-7EEC-4F18-A696-7E665E2372E3Q39042763-633AF052-1CBF-45BC-8C99-029FF123B24AQ39126968-723345A5-7C54-4507-B9FB-C067D7F767B0Q39260867-74A713F7-C6FC-44CF-A683-6C2359C72ACDQ39691102-A5A2D569-63C3-4863-8CA7-7786DFFB7581Q39902180-56A45C52-D0C8-4D60-B08D-56CEF50D616CQ40126119-373B7C28-4ADF-4CD8-9EB9-3CA9AA8D78EDQ40280680-A1703D72-6992-46C8-9101-D317A347C059Q40455602-8989805B-2D72-4582-9014-2A0741E1DB0AQ40925694-E0500010-CF3A-4D2A-9D18-AD5670DECF2BQ41732794-D26999A7-F4B1-40F2-B1F3-9E90428E4898Q45394953-97972980-6239-4D27-AAAF-74C409F4DAB8Q47231253-2FA0B5DB-C64A-49B2-BC94-12DAE9ED3DC3Q47264460-4AD655E6-02F7-4293-B03E-A01B2F30DC5EQ47395399-6F98FEEE-153C-40D6-BD89-0C6841B8C0C5Q47715686-0677B487-A7FF-40EB-9785-59EDA68EC5DAQ47781946-374F2DCC-6EE4-40E1-B5FB-C0439D407BEDQ50052721-B4DC31F5-9EEB-45D8-8834-4A276ADDE7E4Q50057670-95BE27BC-9FD5-4E07-9AA7-6E7E2B55EB33Q50558614-5AF4A1B3-EB5A-42A1-918E-E34852A8D27EQ50581489-557584A2-22EE-4F22-B308-18AC0A62C22FQ50745850-6EB66810-E073-459D-A988-16EC4F848BB5Q55037486-24212688-EDA1-4A15-91AF-1D1DDDB71EBBQ55240142-A10C0004-2721-4C28-956B-3B81B255F994Q57286743-F4B5ABD2-3A47-4192-A683-E3EE26E3805DQ57289044-92C38FCB-477D-4A0B-A401-8B7CF0539EAAQ84327108-0E3CD3EB-04C4-408B-A0BD-3E805D4DFC42Q84594309-EEB952BA-7CBB-4F0E-AFFD-AA99784F36F5Q87052322-E5516552-6BBE-4A85-8FC6-C7D7C7BEA961Q87079744-DEE325EE-6657-41E1-8CD2-091F7B7BB02BQ87145436-CBAFA5F0-4FB1-44C3-919B-7B5E7C195CDFQ87336763-672F2655-2B08-4B70-A979-EB683BAF3737Q88434779-19332328-7E2E-4072-B555-C72BEA3BE25EQ89256527-6D92E3FA-F7FF-4B83-BFBC-561182352F24Q90009090-D564191C-2BD6-413A-88E1-A91103FAD87FQ91035556-99128DC9-F5C5-4BD0-80CD-3AD1AD3C2C89Q91253371-2EE2B337-8F49-4333-B80A-D3B53727F2C6
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Salvatore Gueli Alletti
@ast
Salvatore Gueli Alletti
@en
Salvatore Gueli Alletti
@es
Salvatore Gueli Alletti
@nl
type
label
Salvatore Gueli Alletti
@ast
Salvatore Gueli Alletti
@en
Salvatore Gueli Alletti
@es
Salvatore Gueli Alletti
@nl
prefLabel
Salvatore Gueli Alletti
@ast
Salvatore Gueli Alletti
@en
Salvatore Gueli Alletti
@es
Salvatore Gueli Alletti
@nl
P106
P1153
55018119000
57192819621
P31
P496
0000-0003-3886-3007